The Globe and Mail reports in its Friday, June 23, edition that Scotia Capital analyst Mario Saric continues to rate Northwest Healthcare Properties REIT "sector perform." The Globe's David Leeder writes in the Eye On Equities column that Mr. Saric trimmed his unit target by $1.50 to $9.50. Analysts on average target the units at $10. Mr. Saric shaved his unit target following the termination of Northwest Healthcare's UK joint venture plan. Mr. Saric says in a note: "We believe market perception of Northwest Healthcare asset management franchise may erode (we lowered our value by $120-million to $486-million). Bottom-line, while we still believe there is legitimate value in Northwest Healthcare, we don't see much upside in the next 3-4 months." The Globe reported on July 5, 2022, that BMO Capital Markets analyst Jenny Ma had upgraded Northwest to "outperform" from "market perform." It was then worth $12.38. The Globe reported on Nov. 22, 2022, that RBC Capital analyst Pammi Bir had reaffirmed Northwest at "sector perform." It was then worth $10.16. The Globe reported on April 4, 2023, that Mr. Bir, while keeping his "sector perform" recommendation, said Northwest had "sound fundamentals." It was then worth $8.28.